A Non-interventional, Real-world Study on the Adjuvant Treatment of Chinese EGFR-positive Stage IA NSCLC Patients With High-risk Factors Using Third-generation EGFR-TKIs.

Clinical trial NCT07686185 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07686185
Sponsor: First Affiliated Hospital of Guangxi Medical University
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer Adjuvant Therapy

Start date: 2026-09-01
Primary completion: 2031-09-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.